Robert C. Goeltz II
2016 - CytomX Therapeutics
In 2016, Robert C. Goeltz II earned a total compensation of $1.3M as Chief Financial Officer and Secretary at CytomX Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $128,975 |
|---|---|
| Option Awards | $786,968 |
| Salary | $335,000 |
| Other | $3,540 |
| Total | $1,254,483 |
Goeltz received $787K in option awards, accounting for 63% of the total pay in 2016.
Goeltz also received $129K in non-equity incentive plan, $335K in salary and $3.5K in other compensation.
Rankings
In 2016, Robert C. Goeltz II's compensation ranked 7,162nd out of 14,075 executives tracked by ExecPay. In other words, Goeltz earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,162 out of 14,075 | 49th |
Division Manufacturing | 2,698 out of 5,489 | 51st |
Major group Chemicals And Allied Products | 883 out of 1,895 | 53rd |
Industry group Drugs | 683 out of 1,538 | 56th |
Industry Pharmaceutical Preparations | 543 out of 1,176 | 54th |
Source: SEC filing on May 9, 2017.
Goeltz's colleagues
We found three more compensation records of executives who worked with Robert C. Goeltz II at CytomX Therapeutics in 2016.